172 related articles for article (PubMed ID: 38686208)
1. Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma.
Zhu JQ; Liu JZ; Yang SW; Ren ZY; Ye XY; Liu Z; Li XL; Han DD; He Q
Front Endocrinol (Lausanne); 2024; 15():1306091. PubMed ID: 38686208
[TBL] [Abstract][Full Text] [Related]
2. Impact of metabolic dysfunction-associated fatty liver disease on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma.
Zhu JQ; Ye XY; Yang SW; Liu JZ; Ren ZY; Jia YN; Liu Z; Ding C; Kou JT; Li XL; Han DD; He Q
Eur J Clin Nutr; 2024 Feb; 78(2):107-113. PubMed ID: 37935889
[TBL] [Abstract][Full Text] [Related]
3. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.
Zarrinpar A; Faltermeier CM; Agopian VG; Naini BV; Harlander-Locke MP; Kaldas FM; Farmer DG; Busuttil RW
Liver Int; 2019 Mar; 39(3):531-539. PubMed ID: 30427105
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
5. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
[TBL] [Abstract][Full Text] [Related]
8. Effect of ethnicity on liver transplant for hepatocellular carcinoma.
Couto CA; Gelape CL; Calmet F; Martin P; Levy C
Exp Clin Transplant; 2013 Aug; 11(4):339-45. PubMed ID: 23905912
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium.
Verna EC; Phipps MM; Halazun KJ; Markovic D; Florman SS; Haydel BM; Ruiz R; Klintmalm G; Lee DD; Taner B; Hoteit MA; Tevar AD; Humar A; Chapman WC; Vachharajani N; Aucejo FN; Melcher ML; Nguyen MH; Nydam TL; Markmann JF; Mobley C; Ghobrial RM; Langnas AN; Carney C; Berumen J; Schnickel GT; Sudan D; Hong JC; Rana A; Jones CM; Fishbein TM; Busuttil RW; Agopian V;
Liver Transpl; 2023 Jan; 29(1):34-47. PubMed ID: 36630156
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
12. Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
Adams LA; Arauz O; Angus PW; Sinclair M; MacDonald GA; Chelvaratnam U; Wigg AJ; Yeap S; Shackel N; Lin L; Raftopoulos S; McCaughan GW; Jeffrey GP;
J Gastroenterol Hepatol; 2016 May; 31(5):1016-24. PubMed ID: 26589875
[TBL] [Abstract][Full Text] [Related]
13. Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant.
Gitto S; Villa E
Int J Mol Sci; 2016 Apr; 17(4):490. PubMed ID: 27049380
[TBL] [Abstract][Full Text] [Related]
14. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
[TBL] [Abstract][Full Text] [Related]
15. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
[TBL] [Abstract][Full Text] [Related]
16. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
[TBL] [Abstract][Full Text] [Related]
17. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
19. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
Bertot LC; Adams LA
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
[TBL] [Abstract][Full Text] [Related]
20. Single-Center Experience of Recurrence Patterns and Survival Analyses of Patients With Hepatocellular Carcinoma and Liver Transplant.
Rahatli S; Ayvazoglu Soy EH; Oguz A; Altundag O; Moray G; Haberal M
Exp Clin Transplant; 2020 Apr; 18(2):201-205. PubMed ID: 32279656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
